Intuitive Surgical (NASDAQ:ISRG) Given New $674.00 Price Target at Barclays

Intuitive Surgical (NASDAQ:ISRG) had its price target boosted by Barclays from $610.00 to $674.00 in a research note published on Monday.

Other analysts also recently issued research reports about the stock. Wells Fargo & Company lifted their target price on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a report on Friday. The Goldman Sachs Group set a $604.00 price objective on shares of Intuitive Surgical in a research report on Friday, October 18th. Robert W. Baird upped their price target on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. JPMorgan Chase & Co. raised their price objective on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a report on Friday. Finally, Truist Financial raised their target price on shares of Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a research report on Friday. One analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Stock Down 1.8 %

Shares of NASDAQ ISRG opened at $573.48 on Monday. The stock has a market capitalization of $204.26 billion, a price-to-earnings ratio of 92.20, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39. The firm has a 50-day simple moving average of $547.16 and a 200-day simple moving average of $505.21. Intuitive Surgical has a 52 week low of $364.17 and a 52 week high of $616.00.

Insider Buying and Selling

In related news, CFO Jamie Samath sold 108 shares of the business’s stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,746,819.42. The trade was a 1.22 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Gary S. Guthart sold 18,151 shares of the company’s stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the sale, the chief executive officer now owns 24,219 shares of the company’s stock, valued at $12,391,166.97. This trade represents a 42.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 42,265 shares of company stock valued at $21,964,281. Corporate insiders own 0.90% of the company’s stock.

Hedge Funds Weigh In On Intuitive Surgical

A number of hedge funds have recently modified their holdings of the stock. AQR Capital Management LLC raised its stake in shares of Intuitive Surgical by 12.6% during the second quarter. AQR Capital Management LLC now owns 42,691 shares of the medical equipment provider’s stock worth $18,958,000 after buying an additional 4,775 shares during the last quarter. Creative Planning lifted its position in Intuitive Surgical by 9.8% in the 2nd quarter. Creative Planning now owns 63,039 shares of the medical equipment provider’s stock valued at $28,043,000 after acquiring an additional 5,629 shares in the last quarter. NewEdge Advisors LLC boosted its position in shares of Intuitive Surgical by 8.2% during the second quarter. NewEdge Advisors LLC now owns 13,825 shares of the medical equipment provider’s stock worth $6,150,000 after buying an additional 1,044 shares during the period. Northwestern Mutual Wealth Management Co. grew its stake in shares of Intuitive Surgical by 2.1% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 20,458 shares of the medical equipment provider’s stock worth $9,100,000 after acquiring an additional 411 shares in the last quarter. Finally, Wellington Wealth Strategies LLC. acquired a new stake in Intuitive Surgical in the 2nd quarter valued at $241,000. 83.64% of the stock is owned by institutional investors and hedge funds.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.